Both agents affect the vascular system through separate mechanisms that could produce additive effects on bleeding risk
Low Blood Sugar: Possible, especially when combined with other diabetes medications
A 10 mg vial covers 20 weeks at 0.5 mg, 10 weeks at 1 mg, 5 weeks at 2 mg, and about 2.5 weeks at 4 mg weekly
In contrast with this expected effect, eGFR does not change in patients with T2DM in response to GLP-1 RA in response to chronic treatment
GLP-1s have emerged as a promising treatment to halt or even reverse the effects of NAFLD, largely due to the effects on weight loss and insulin secretion, but there is increasing evidence that GLP-1s may have more direct effects on the liver and benefits in the treatment of NAFLD
[9] Semaglutide Efficacy at Low Doses: Slower Progress, Better Comfort Semaglutide (Ozempic/Wegovy) is the most common drug for microdosing, largely because its pen design allows for the click method, a technique I explain step-by-step later in the article